SLC25A16 and glioblastoma: Gene set enrichment analysis showed that DEGs were significantly enriched in the MAPK and mTOR signaling pathways after combination therapy and caused significant suppression of the MAPK and mTOR signaling pathways, which may contribute to the inhibitory effects of AZD + GDC treatment on GBM cell proliferation (Fig. 3B).